Today: 4 May 2026

Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper Corp fell 2.8% to $145.30 late Monday, tracking a sharp selloff in metals after CME Group raised margin requirements. Spot gold dropped 4.5%, silver 9.5%, and copper 4.8%, pressuring mining stocks. About 1.1 million SCCO shares traded between $143.75 and $149.00. Investors await Fed minutes Tuesday and Southern Copper’s earnings in February.
30 December 2025
··
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk is cutting Wegovy prices in China, with local reports citing 48% reductions for the highest doses in Yunnan and Sichuan. The move comes as the company faces a 2026 patent expiry for semaglutide and rising competition from Chinese drugmakers. Novo shares fell after the China pricing news circulated. The company did not disclose exact new prices in its statement.
30 December 2025
·
Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices Inc shares fell 0.44% to $275.63 Monday, marking a second straight decline. The Philadelphia Semiconductor Index dropped 31.94 points to 7,178.27 as chip stocks tracked a weaker U.S. market. Investors await Federal Reserve minutes Tuesday after policymakers cut rates but signaled caution. Analog Devices last issued upbeat guidance in late November, projecting fiscal Q1 revenue above analyst estimates.
30 December 2025
···
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead Sciences shares closed up 0.15% at $124.91 on Monday after Bernstein said new Medicaid drug-pricing rules would have limited impact on its HIV drug Biktarvy. Bernstein estimated less than $200 million in 2026 revenue impact for older HIV drugs Genvoya and Odefsey. Investors await more details from the Trump administration’s pricing rollout and Gilead’s update at the J.P. Morgan Healthcare Conference in January.
30 December 2025
·
Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed Martin has offered to set up a C-130J Super Hercules final-assembly line in India as it competes for a contract to supply up to 80 military transport aircraft. India is the only location outside the U.S. under consideration for C-130J co-production, a Lockheed executive said. Rival bids include Embraer and Airbus. Some Indian media report the air force has dropped plans for more C-130Js and is focusing on a new medium transport aircraft program.
30 December 2025
·
Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol shares closed down 0.4% at $136.90 Monday as tech stocks dragged U.S. markets lower in thin year-end trading. The stock traded between $135.83 and $137.59 on volume of 4.3 million shares. Amphenol will report fourth-quarter results on Jan. 28. Investors are watching upcoming U.S. economic data and Federal Reserve minutes for further direction.
30 December 2025
·······
AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

Applied Materials shares closed up 0.44% at $263.05 Monday, near their 52-week high, as broader markets slipped and trading volume remained light. The stock outperformed peers Lam Research and KLA, which both declined. Investors remain focused on U.S. export controls affecting China sales and upcoming earnings, expected Feb. 12, 2026. After-hours, Applied Materials dipped 0.13%.
30 December 2025
·
1 … 928 929 930 931 932 … 1,894

Stock Market Today

  • Nvidia Stock Split History and Timing for Next Split
    May 3, 2026, 8:35 PM EDT. Nvidia's shares have surged over 500,000% since 1999, driven by growth in artificial intelligence chip demand. The company has split its stock six times since 2000, totaling a 480-for-1 ratio. Recent splits in 2021 and 2024 occurred at much higher prices, reducing shares from $750 and $1,200 down to around $190 and $120, respectively. Currently trading near $200, Nvidia would likely need a significant price jump-potentially doubling-to trigger the next split. Given its $4.8 trillion market cap and ongoing expansion, a split is probable but not imminent within a few years.

Latest article

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

4 May 2026
Navitas Semiconductor shares rose 5.76% to $17.45 Friday on heavy volume ahead of first-quarter results due Tuesday. The company forecast Q1 revenue of $8.0–$8.5 million after posting a $41.4 million loss last quarter. Management highlighted new high-power chips for AI data centers but warned that design wins do not guarantee near-term sales. CEO Chris Allexandre and CFO Tonya Stevens will discuss results May 5.
Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

4 May 2026
Eaton will report first-quarter results before the NYSE opens Tuesday, following its Boyd Thermal acquisition and push into AI data-center power systems. Shares closed Friday at $425.55, down 1.72%, with a market value near $166 billion. Wall Street expects adjusted earnings of $2.75 per share for the March quarter. Investors are watching for signs that AI data-center demand is driving orders and profit.
Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

4 May 2026
Brown University cut its stake in Blue Owl Capital Corp’s main private-credit fund by 53%, holding 1.5 million OBDC shares at March 31, down from 3.2 million at the end of 2025. Blue Owl’s quarterly filing showed revenue rose to $753.8 million, net income doubled to $15.5 million, but its direct-lending strategy posted a 1.1% net loss as repayments outpaced new loans.
Go toTop